Pharmacokinetics of BIBR277 (Telmisartan) in patients with essential hypertension

Japanese Pharmacology and Therapeutics

Volumn 30, Issue SUPPL. 1, 2002, Pages

  Ogihara, Toshio ^a   Takaori, Akifumi ^a   Taki, Chouji ^a   Asai, Yasushi ^a   Yajima, Kazuhiro ^a   Fukuda, Hidekazu ^a   Tatami, Shinji ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TELMISARTAN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GOOD CLINICAL PRACTICE; HUMAN; MALE; SYSTOLIC BLOOD PRESSURE;

EID: 0036029506     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Yong CL, et al. Multiple-dose pharmacokinetics of Telmisartan and of Hydrochlorothiazide following concurrent administration in healthy subjects. Clin Pharmacol 2000; 40: 1323-30.
2. Schmid J, et al. In vivo and in vitro biotransformation of Telmisartan. 1st Int Symp on Angiotensin II Antagonism, London 1997; p. 13.
3. Ebner T, et al. In vitro glucuronidation of Telmisartan, a novel angiotensin II receptor antagonist. 2nd Int Symp on Angiotensinn II Antagonism, London 1999; p. 44.
4. Busch U, et al. Special in vitro and in vivo investigations on the pharmacokinetics of Telmisartan and its glucuronide. 2nd Int Symp on Angiotensin II Antagonism, London 1999; 41P